Homeostasis of phospholipids — The level of phosphatidylethanolamine tightly adapts to changes in ethanolamine plasmalogens

Ethanolamine plasmalogens constitute a group of ether glycerophospholipids that, due to their unique biophysical and biochemical properties, are essential components of mammalian cellular membranes. Their importance is emphasized by the consequences of defects in plasmalogen biosynthesis, which in h...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochimica et biophysica acta 2015-02, Vol.1851 (2), p.117-128
Hauptverfasser: Dorninger, Fabian, Brodde, Alexander, Braverman, Nancy E., Moser, Ann B., Just, Wilhelm W., Forss-Petter, Sonja, Brügger, Britta, Berger, Johannes
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 128
container_issue 2
container_start_page 117
container_title Biochimica et biophysica acta
container_volume 1851
creator Dorninger, Fabian
Brodde, Alexander
Braverman, Nancy E.
Moser, Ann B.
Just, Wilhelm W.
Forss-Petter, Sonja
Brügger, Britta
Berger, Johannes
description Ethanolamine plasmalogens constitute a group of ether glycerophospholipids that, due to their unique biophysical and biochemical properties, are essential components of mammalian cellular membranes. Their importance is emphasized by the consequences of defects in plasmalogen biosynthesis, which in humans cause the fatal disease rhizomelic chondrodysplasia punctata (RCDP). In the present lipidomic study, we used fibroblasts derived from RCDP patients, as well as brain tissue from plasmalogen-deficient mice, to examine the compensatory mechanisms of lipid homeostasis in response to plasmalogen deficiency. Our results show that phosphatidylethanolamine (PE), a diacyl glycerophospholipid, which like ethanolamine plasmalogens carries the head group ethanolamine, is the main player in the adaptation to plasmalogen insufficiency. PE levels were tightly adjusted to the amount of ethanolamine plasmalogens so that their combined levels were kept constant. Similarly, the total amount of polyunsaturated fatty acids (PUFAs) in ethanolamine phospholipids was maintained upon plasmalogen deficiency. However, we found an increased incorporation of arachidonic acid at the expense of docosahexaenoic acid in the PE fraction of plasmalogen-deficient tissues. These data show that under conditions of reduced plasmalogen levels, the amount of total ethanolamine phospholipids is precisely maintained by a rise in PE. At the same time, a shift in the ratio between ω-6 and ω-3 PUFAs occurs, which might have unfavorable, long-term biological consequences. Therefore, our findings are not only of interest for RCDP but may have more widespread implications also for other disease conditions, as for example Alzheimer's disease, that have been associated with a decline in plasmalogens. •PE accurately compensates for the lack of plasmalogens in vitro and in vivo.•PE levels decrease to adapt to excess of ethanolamine plasmalogens (PlsEtn).•Plasmalogen deficiency favors incorporation of arachidonic acid into PE.•Docosahexaenoic acid in ethanolamine phospholipids decreases upon PlsEtn depletion.
doi_str_mv 10.1016/j.bbalip.2014.11.005
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2000333462</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1388198114002443</els_id><sourcerecordid>1645773065</sourcerecordid><originalsourceid>FETCH-LOGICAL-c665t-d17dfaef77db0bf251cb947bd79737db5712d447ba3e0375b1bc02fd2209730f3</originalsourceid><addsrcrecordid>eNqFks9u1DAQxiMEoqXwBgj5yCXB4z9xckFCFbRIlbiUs-XEk41XThxi70p7QOIheEKepK62tPRCD5atmd984xl9RfEWaAUU6g_bquuMd0vFKIgKoKJUPitOoVFtyWponuc3b5oS2gZOilcxbikFybl8WZwwKWouVHta_LwME4aYTHSRhIEsY4j5ZF1nI_nz6ze5HpF43KN_SJvk7MFjGs0cvJncjCS5zZj8gRhrlhRJCqTP2Q1G4mbyiFy8iZPxYYNzfF28GIyP-ObuPiu-f_l8fX5ZXn27-Hr-6ars61qm0oKyg8FBKdvRbmAS-q4VqrOqVTzHpAJmRQ4YjpQr2UHXUzZYxmgG6MDPio9H3WXXTWh7nNNqvF5WN5n1oINx-nFmdqPehL0WnEOtRBZ4fyewhh87jElPLvbovZkx7KJmlFLOuajZkyg0jLdCSoCn0VpIlQeoZUbFEe3XEOOKw_3ngepbP-itPvpB3_pBA-jsh1z27t_B74v-GuBhM5jXv3e46tg7nHu0bsU-aRvc_zvcANvazQg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1645773065</pqid></control><display><type>article</type><title>Homeostasis of phospholipids — The level of phosphatidylethanolamine tightly adapts to changes in ethanolamine plasmalogens</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Dorninger, Fabian ; Brodde, Alexander ; Braverman, Nancy E. ; Moser, Ann B. ; Just, Wilhelm W. ; Forss-Petter, Sonja ; Brügger, Britta ; Berger, Johannes</creator><creatorcontrib>Dorninger, Fabian ; Brodde, Alexander ; Braverman, Nancy E. ; Moser, Ann B. ; Just, Wilhelm W. ; Forss-Petter, Sonja ; Brügger, Britta ; Berger, Johannes</creatorcontrib><description>Ethanolamine plasmalogens constitute a group of ether glycerophospholipids that, due to their unique biophysical and biochemical properties, are essential components of mammalian cellular membranes. Their importance is emphasized by the consequences of defects in plasmalogen biosynthesis, which in humans cause the fatal disease rhizomelic chondrodysplasia punctata (RCDP). In the present lipidomic study, we used fibroblasts derived from RCDP patients, as well as brain tissue from plasmalogen-deficient mice, to examine the compensatory mechanisms of lipid homeostasis in response to plasmalogen deficiency. Our results show that phosphatidylethanolamine (PE), a diacyl glycerophospholipid, which like ethanolamine plasmalogens carries the head group ethanolamine, is the main player in the adaptation to plasmalogen insufficiency. PE levels were tightly adjusted to the amount of ethanolamine plasmalogens so that their combined levels were kept constant. Similarly, the total amount of polyunsaturated fatty acids (PUFAs) in ethanolamine phospholipids was maintained upon plasmalogen deficiency. However, we found an increased incorporation of arachidonic acid at the expense of docosahexaenoic acid in the PE fraction of plasmalogen-deficient tissues. These data show that under conditions of reduced plasmalogen levels, the amount of total ethanolamine phospholipids is precisely maintained by a rise in PE. At the same time, a shift in the ratio between ω-6 and ω-3 PUFAs occurs, which might have unfavorable, long-term biological consequences. Therefore, our findings are not only of interest for RCDP but may have more widespread implications also for other disease conditions, as for example Alzheimer's disease, that have been associated with a decline in plasmalogens. •PE accurately compensates for the lack of plasmalogens in vitro and in vivo.•PE levels decrease to adapt to excess of ethanolamine plasmalogens (PlsEtn).•Plasmalogen deficiency favors incorporation of arachidonic acid into PE.•Docosahexaenoic acid in ethanolamine phospholipids decreases upon PlsEtn depletion.</description><identifier>ISSN: 1388-1981</identifier><identifier>ISSN: 0006-3002</identifier><identifier>EISSN: 1879-2618</identifier><identifier>DOI: 10.1016/j.bbalip.2014.11.005</identifier><identifier>PMID: 25463479</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Acyltransferases - deficiency ; Acyltransferases - genetics ; Adaptation, Physiological ; Alzheimer disease ; Alzheimer's disease ; Animals ; Arachidonic acid ; Arachidonic Acid - metabolism ; biosynthesis ; brain ; cell membranes ; Cells, Cultured ; Chondrodysplasia Punctata, Rhizomelic - enzymology ; Chondrodysplasia Punctata, Rhizomelic - genetics ; Compensation ; Disease Models, Animal ; Docosahexaenoic acid ; Docosahexaenoic Acids - metabolism ; ethanolamine ; fibroblasts ; Fibroblasts - enzymology ; Genetic Predisposition to Disease ; Gray Matter - enzymology ; Homeostasis ; Humans ; mice ; Mice, Inbred C57BL ; Mice, Knockout ; omega-3 fatty acids ; patients ; Peroxisome ; Phenotype ; phosphatidylethanolamines ; Phosphatidylethanolamines - metabolism ; Plasmalogen ; Plasmalogens - metabolism ; Severity of Illness Index</subject><ispartof>Biochimica et biophysica acta, 2015-02, Vol.1851 (2), p.117-128</ispartof><rights>2014</rights><rights>Copyright © 2014. Published by Elsevier B.V.</rights><rights>2014 The Authors. Published by Elsevier B.V. 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c665t-d17dfaef77db0bf251cb947bd79737db5712d447ba3e0375b1bc02fd2209730f3</citedby><cites>FETCH-LOGICAL-c665t-d17dfaef77db0bf251cb947bd79737db5712d447ba3e0375b1bc02fd2209730f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1388198114002443$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25463479$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dorninger, Fabian</creatorcontrib><creatorcontrib>Brodde, Alexander</creatorcontrib><creatorcontrib>Braverman, Nancy E.</creatorcontrib><creatorcontrib>Moser, Ann B.</creatorcontrib><creatorcontrib>Just, Wilhelm W.</creatorcontrib><creatorcontrib>Forss-Petter, Sonja</creatorcontrib><creatorcontrib>Brügger, Britta</creatorcontrib><creatorcontrib>Berger, Johannes</creatorcontrib><title>Homeostasis of phospholipids — The level of phosphatidylethanolamine tightly adapts to changes in ethanolamine plasmalogens</title><title>Biochimica et biophysica acta</title><addtitle>Biochim Biophys Acta</addtitle><description>Ethanolamine plasmalogens constitute a group of ether glycerophospholipids that, due to their unique biophysical and biochemical properties, are essential components of mammalian cellular membranes. Their importance is emphasized by the consequences of defects in plasmalogen biosynthesis, which in humans cause the fatal disease rhizomelic chondrodysplasia punctata (RCDP). In the present lipidomic study, we used fibroblasts derived from RCDP patients, as well as brain tissue from plasmalogen-deficient mice, to examine the compensatory mechanisms of lipid homeostasis in response to plasmalogen deficiency. Our results show that phosphatidylethanolamine (PE), a diacyl glycerophospholipid, which like ethanolamine plasmalogens carries the head group ethanolamine, is the main player in the adaptation to plasmalogen insufficiency. PE levels were tightly adjusted to the amount of ethanolamine plasmalogens so that their combined levels were kept constant. Similarly, the total amount of polyunsaturated fatty acids (PUFAs) in ethanolamine phospholipids was maintained upon plasmalogen deficiency. However, we found an increased incorporation of arachidonic acid at the expense of docosahexaenoic acid in the PE fraction of plasmalogen-deficient tissues. These data show that under conditions of reduced plasmalogen levels, the amount of total ethanolamine phospholipids is precisely maintained by a rise in PE. At the same time, a shift in the ratio between ω-6 and ω-3 PUFAs occurs, which might have unfavorable, long-term biological consequences. Therefore, our findings are not only of interest for RCDP but may have more widespread implications also for other disease conditions, as for example Alzheimer's disease, that have been associated with a decline in plasmalogens. •PE accurately compensates for the lack of plasmalogens in vitro and in vivo.•PE levels decrease to adapt to excess of ethanolamine plasmalogens (PlsEtn).•Plasmalogen deficiency favors incorporation of arachidonic acid into PE.•Docosahexaenoic acid in ethanolamine phospholipids decreases upon PlsEtn depletion.</description><subject>Acyltransferases - deficiency</subject><subject>Acyltransferases - genetics</subject><subject>Adaptation, Physiological</subject><subject>Alzheimer disease</subject><subject>Alzheimer's disease</subject><subject>Animals</subject><subject>Arachidonic acid</subject><subject>Arachidonic Acid - metabolism</subject><subject>biosynthesis</subject><subject>brain</subject><subject>cell membranes</subject><subject>Cells, Cultured</subject><subject>Chondrodysplasia Punctata, Rhizomelic - enzymology</subject><subject>Chondrodysplasia Punctata, Rhizomelic - genetics</subject><subject>Compensation</subject><subject>Disease Models, Animal</subject><subject>Docosahexaenoic acid</subject><subject>Docosahexaenoic Acids - metabolism</subject><subject>ethanolamine</subject><subject>fibroblasts</subject><subject>Fibroblasts - enzymology</subject><subject>Genetic Predisposition to Disease</subject><subject>Gray Matter - enzymology</subject><subject>Homeostasis</subject><subject>Humans</subject><subject>mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>omega-3 fatty acids</subject><subject>patients</subject><subject>Peroxisome</subject><subject>Phenotype</subject><subject>phosphatidylethanolamines</subject><subject>Phosphatidylethanolamines - metabolism</subject><subject>Plasmalogen</subject><subject>Plasmalogens - metabolism</subject><subject>Severity of Illness Index</subject><issn>1388-1981</issn><issn>0006-3002</issn><issn>1879-2618</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFks9u1DAQxiMEoqXwBgj5yCXB4z9xckFCFbRIlbiUs-XEk41XThxi70p7QOIheEKepK62tPRCD5atmd984xl9RfEWaAUU6g_bquuMd0vFKIgKoKJUPitOoVFtyWponuc3b5oS2gZOilcxbikFybl8WZwwKWouVHta_LwME4aYTHSRhIEsY4j5ZF1nI_nz6ze5HpF43KN_SJvk7MFjGs0cvJncjCS5zZj8gRhrlhRJCqTP2Q1G4mbyiFy8iZPxYYNzfF28GIyP-ObuPiu-f_l8fX5ZXn27-Hr-6ars61qm0oKyg8FBKdvRbmAS-q4VqrOqVTzHpAJmRQ4YjpQr2UHXUzZYxmgG6MDPio9H3WXXTWh7nNNqvF5WN5n1oINx-nFmdqPehL0WnEOtRBZ4fyewhh87jElPLvbovZkx7KJmlFLOuajZkyg0jLdCSoCn0VpIlQeoZUbFEe3XEOOKw_3ngepbP-itPvpB3_pBA-jsh1z27t_B74v-GuBhM5jXv3e46tg7nHu0bsU-aRvc_zvcANvazQg</recordid><startdate>20150201</startdate><enddate>20150201</enddate><creator>Dorninger, Fabian</creator><creator>Brodde, Alexander</creator><creator>Braverman, Nancy E.</creator><creator>Moser, Ann B.</creator><creator>Just, Wilhelm W.</creator><creator>Forss-Petter, Sonja</creator><creator>Brügger, Britta</creator><creator>Berger, Johannes</creator><general>Elsevier B.V</general><general>Elsevier Pub. Co</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7S9</scope><scope>L.6</scope><scope>5PM</scope></search><sort><creationdate>20150201</creationdate><title>Homeostasis of phospholipids — The level of phosphatidylethanolamine tightly adapts to changes in ethanolamine plasmalogens</title><author>Dorninger, Fabian ; Brodde, Alexander ; Braverman, Nancy E. ; Moser, Ann B. ; Just, Wilhelm W. ; Forss-Petter, Sonja ; Brügger, Britta ; Berger, Johannes</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c665t-d17dfaef77db0bf251cb947bd79737db5712d447ba3e0375b1bc02fd2209730f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Acyltransferases - deficiency</topic><topic>Acyltransferases - genetics</topic><topic>Adaptation, Physiological</topic><topic>Alzheimer disease</topic><topic>Alzheimer's disease</topic><topic>Animals</topic><topic>Arachidonic acid</topic><topic>Arachidonic Acid - metabolism</topic><topic>biosynthesis</topic><topic>brain</topic><topic>cell membranes</topic><topic>Cells, Cultured</topic><topic>Chondrodysplasia Punctata, Rhizomelic - enzymology</topic><topic>Chondrodysplasia Punctata, Rhizomelic - genetics</topic><topic>Compensation</topic><topic>Disease Models, Animal</topic><topic>Docosahexaenoic acid</topic><topic>Docosahexaenoic Acids - metabolism</topic><topic>ethanolamine</topic><topic>fibroblasts</topic><topic>Fibroblasts - enzymology</topic><topic>Genetic Predisposition to Disease</topic><topic>Gray Matter - enzymology</topic><topic>Homeostasis</topic><topic>Humans</topic><topic>mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>omega-3 fatty acids</topic><topic>patients</topic><topic>Peroxisome</topic><topic>Phenotype</topic><topic>phosphatidylethanolamines</topic><topic>Phosphatidylethanolamines - metabolism</topic><topic>Plasmalogen</topic><topic>Plasmalogens - metabolism</topic><topic>Severity of Illness Index</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dorninger, Fabian</creatorcontrib><creatorcontrib>Brodde, Alexander</creatorcontrib><creatorcontrib>Braverman, Nancy E.</creatorcontrib><creatorcontrib>Moser, Ann B.</creatorcontrib><creatorcontrib>Just, Wilhelm W.</creatorcontrib><creatorcontrib>Forss-Petter, Sonja</creatorcontrib><creatorcontrib>Brügger, Britta</creatorcontrib><creatorcontrib>Berger, Johannes</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>AGRICOLA</collection><collection>AGRICOLA - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Biochimica et biophysica acta</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dorninger, Fabian</au><au>Brodde, Alexander</au><au>Braverman, Nancy E.</au><au>Moser, Ann B.</au><au>Just, Wilhelm W.</au><au>Forss-Petter, Sonja</au><au>Brügger, Britta</au><au>Berger, Johannes</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Homeostasis of phospholipids — The level of phosphatidylethanolamine tightly adapts to changes in ethanolamine plasmalogens</atitle><jtitle>Biochimica et biophysica acta</jtitle><addtitle>Biochim Biophys Acta</addtitle><date>2015-02-01</date><risdate>2015</risdate><volume>1851</volume><issue>2</issue><spage>117</spage><epage>128</epage><pages>117-128</pages><issn>1388-1981</issn><issn>0006-3002</issn><eissn>1879-2618</eissn><abstract>Ethanolamine plasmalogens constitute a group of ether glycerophospholipids that, due to their unique biophysical and biochemical properties, are essential components of mammalian cellular membranes. Their importance is emphasized by the consequences of defects in plasmalogen biosynthesis, which in humans cause the fatal disease rhizomelic chondrodysplasia punctata (RCDP). In the present lipidomic study, we used fibroblasts derived from RCDP patients, as well as brain tissue from plasmalogen-deficient mice, to examine the compensatory mechanisms of lipid homeostasis in response to plasmalogen deficiency. Our results show that phosphatidylethanolamine (PE), a diacyl glycerophospholipid, which like ethanolamine plasmalogens carries the head group ethanolamine, is the main player in the adaptation to plasmalogen insufficiency. PE levels were tightly adjusted to the amount of ethanolamine plasmalogens so that their combined levels were kept constant. Similarly, the total amount of polyunsaturated fatty acids (PUFAs) in ethanolamine phospholipids was maintained upon plasmalogen deficiency. However, we found an increased incorporation of arachidonic acid at the expense of docosahexaenoic acid in the PE fraction of plasmalogen-deficient tissues. These data show that under conditions of reduced plasmalogen levels, the amount of total ethanolamine phospholipids is precisely maintained by a rise in PE. At the same time, a shift in the ratio between ω-6 and ω-3 PUFAs occurs, which might have unfavorable, long-term biological consequences. Therefore, our findings are not only of interest for RCDP but may have more widespread implications also for other disease conditions, as for example Alzheimer's disease, that have been associated with a decline in plasmalogens. •PE accurately compensates for the lack of plasmalogens in vitro and in vivo.•PE levels decrease to adapt to excess of ethanolamine plasmalogens (PlsEtn).•Plasmalogen deficiency favors incorporation of arachidonic acid into PE.•Docosahexaenoic acid in ethanolamine phospholipids decreases upon PlsEtn depletion.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>25463479</pmid><doi>10.1016/j.bbalip.2014.11.005</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1388-1981
ispartof Biochimica et biophysica acta, 2015-02, Vol.1851 (2), p.117-128
issn 1388-1981
0006-3002
1879-2618
language eng
recordid cdi_proquest_miscellaneous_2000333462
source MEDLINE; Elsevier ScienceDirect Journals
subjects Acyltransferases - deficiency
Acyltransferases - genetics
Adaptation, Physiological
Alzheimer disease
Alzheimer's disease
Animals
Arachidonic acid
Arachidonic Acid - metabolism
biosynthesis
brain
cell membranes
Cells, Cultured
Chondrodysplasia Punctata, Rhizomelic - enzymology
Chondrodysplasia Punctata, Rhizomelic - genetics
Compensation
Disease Models, Animal
Docosahexaenoic acid
Docosahexaenoic Acids - metabolism
ethanolamine
fibroblasts
Fibroblasts - enzymology
Genetic Predisposition to Disease
Gray Matter - enzymology
Homeostasis
Humans
mice
Mice, Inbred C57BL
Mice, Knockout
omega-3 fatty acids
patients
Peroxisome
Phenotype
phosphatidylethanolamines
Phosphatidylethanolamines - metabolism
Plasmalogen
Plasmalogens - metabolism
Severity of Illness Index
title Homeostasis of phospholipids — The level of phosphatidylethanolamine tightly adapts to changes in ethanolamine plasmalogens
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T05%3A23%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Homeostasis%20of%20phospholipids%20%E2%80%94%20The%20level%20of%20phosphatidylethanolamine%20tightly%20adapts%20to%20changes%20in%20ethanolamine%20plasmalogens&rft.jtitle=Biochimica%20et%20biophysica%20acta&rft.au=Dorninger,%20Fabian&rft.date=2015-02-01&rft.volume=1851&rft.issue=2&rft.spage=117&rft.epage=128&rft.pages=117-128&rft.issn=1388-1981&rft.eissn=1879-2618&rft_id=info:doi/10.1016/j.bbalip.2014.11.005&rft_dat=%3Cproquest_pubme%3E1645773065%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1645773065&rft_id=info:pmid/25463479&rft_els_id=S1388198114002443&rfr_iscdi=true